|Timothy A. Dewhurst||Official Reviewer—Board of Governors||Kaiser Permanente, Washington—Seattle Cardiology Operations Chief|
|Joseph E. Marine||Official Reviewer—ACC Task Force on Clinical Expert Consensus Decision Pathways||Johns Hopkins University School of Medicine—Associate Professor of Medicine|
|Linda A. Briggs||Organizational Reviewer—AANP||The George Washington University School of Nursing—Assistant Professor|
|Mark A. Crowther||Organizational Reviewer—Anticoagulation Forum||McMaster University—Chair of Department of Medicine|
|Eileen Mary Handberg||Organizational Reviewer—ACC and PCNA||University of Florida—Research Professor of Medicine; Director, Clinical Trials Program; Florida CARES & CAP—Program Director|
|Jeffrey Kline||Organizational Reviewer—SAEM||Indiana University School of Medicine—Vice Chair of Research, Department of Emergency Medicine; Professor, Department of Cellular and Integrative Physiology|
|Geno J. Merli||Organizational Reviewer—ACP||Thomas Jefferson University Hospital—Professor; Co-Director, Jefferson Vascular Center|
|Edith A. Nutescu||Organizational Reviewer—ACCP||The University of Illinois at Chicago—Associate Professor; Director, Center for Pharmacoepidemiology and Pharmacoeconomic Research, College of Pharmacy; University of Illinois Hospital and Health Sciences System—Co-Director, Personalized Medicine Program|
|Andrea M. Russo||Organizational Reviewer—HRS||Cooper Medical School of Rowan University—Professor of Medicine; Director, Cardiac Electrophysiology and Arrhythmia Services; Director; CCEP Fellowship|
|Kim K. Birtcher||Content Reviewer—Individual||University of Houston College of Pharmacy—Clinical Professor|
|Michael S. Firstenberg||Content Reviewer—Surgeons' Section Leadership Council||Northeast Ohio Medical Universities—Associate Professor of Surgery and Integrative Medicine; Summa Akron City Hospital—Cardiothoracic Surgeon|
|Ty J. Gluckman||Content Reviewer—ACC Roundtable Participant||Providence Heart and Vascular Institute—Medical Director|
|Bulent Gorenek||Content Reviewer—EP Section Leadership Council||Eskisehir Osmangazi University—Professor, Cardiology Department; Vice Director|
|Christopher B. Granger||Content Reviewer—ACC Roundtable Participant||Duke Clinical Research Institute—Professor of Medicine; Director, Cardiac Care Unit|
|Kousik Krishnan||Content Reviewer—EP Section Leadership Council||Rush University Medical Center—Associate Professor of Medicine & Pediatrics; Director, Clinical Cardiac Electrophysiology Fellowship Program; Director, Arrhythmia Device Clinic; Associate Director, Electrophysiology Lab|
|Pamela B. Morris||Content Reviewer—Task Force on Expert Consensus Decision Pathways||Medical University of South Carolina—Director, Seinsheimer Cardiovascular Health Program; Co-Director, Women's Heart Care|
|Win-Kuang Shen||Content Reviewer—Individual||Mayo Clinic Arizona–Phoenix Campus—Professor of Medicine; Consultant|
|Sarah A. Spinler||Content Reviewer—ACC Roundtable Participant||University of the Sciences Philadelphia College of Pharmacy—Professor of Clinical Pharmacy|
|Karol E. Watson||Content Reviewer—Task Force on Expert Consensus Decision Pathways||UCLA Medical School—Co-Director, UCLA Program in Preventive Cardiology|
This table represents the relationships of reviewers with industry and other entities that were disclosed at the time of peer review and determined to be relevant to this document. It does not necessarily reflect relationships with industry at the time of publication. A person is deemed to have a significant interest in a business if the interest represents ownership of ≥5% of the voting stock or share of the business entity, or ownership of ≥$5,000 of the fair market value of the business entity; or if funds received by the person from the business entity exceed 5% of the person’s gross income for the previous year. A relationship is considered to be modest if it is less than significant under the preceding definition. Relationships that exist with no financial benefit are also included for the purpose of transparency. Relationships in this table are modest unless otherwise noted. Names are listed in alphabetical order within each category of review.
According to the ACC, a person has a relevant relationship IF: a) the relationship or interest relates to the same or similar subject matter, intellectual property or asset, topic, or issue addressed in the document; or b) the company/entity (with whom the relationship exists) makes a drug, drug class, or device addressed in the document, or makes a competing drug or device addressed in the document; or c) the person or a member of the person’s household, has a reasonable potential for financial, professional or other personal gain or loss as a result of the issues/content addressed in the document.
AANP = American Association of Nurse Practitioners; ACC = American College of Cardiology; ACCP = American College of Clinical Pharmacy; ACP = American College of Physicians; CCEP = Clinical Cardiac Electrophysiology; EP = Electrophysiology; HRS = Heart Rhythm Society; NIH = National Institutes of Health; PCNA = Preventative Cardiovascular Nurses Association; SAEM = Society for Academic Emergency Medicine; UCLA = University of Southern California at Los Angeles.